T1	Participants 267 296	obstructive sleep apnea (OSA)
T2	Participants 508 578	Patients were admitted to the laboratory for three consecutive nights.
T3	Participants 784 886	patients received 200 mg modafinil or placebo (n = 21) in a randomized, double-blind, crossover design
T4	Participants 1689 1706	patients with OSA
